Risk factor
Weak & very vulnerable to price shocks
Profitability factor
Favourable analyst view
About
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias....
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. In particular, the stock is overvalued on P/FCF.
Target Price
The average target price of IRTC is 221 and suggests 65% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increas
Buy
Sell